APL-102 Capsule in Patients With Advanced Solid Tumors
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and tolerability of APL-102 Capsule and characterize the
pharmacokinetic (PK) profile in advanced solid tumor patients.